Search Result "Nab-rapamycin"
Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 1 Year: 2011 Page: 24-35
Author(s): Aruni S. Arachchige Don, X. F. Steven Zheng
Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 3 Year: 2009 Page: 262-272
Author(s): Qiang Fu, Jin Sun, Wenping Zhang, Xiaofan Sui, Zhongtian Yan, Zhonggui He
Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatmentof CNS Disorders: Challenges and Possibilities
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 33 Year: 2022 Page: 2742-2757
Author(s): Sanjeeb Kumar Sahoo
The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs
Journal: Clinical Cancer Drugs
Volume: 1 Issue: 2 Year: 2014 Page: 100-115
Author(s): Antonello Di Paolo,Guido Bocci,Romano Danesi
Molecular Targeted Approaches for Treatment of Pancreatic Cancer
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2221-2238
Author(s): Z.Q. Huang, A.K. Saluja, V. Dudeja, S.M. Vickers, D.J. Buchsbaum
Therapeutic Perspectives on Pancreatic Cancer
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 4 Year: 2013 Page: 400-410
Author(s): Anjali V. Sheahan, Phoebe A. Phillips, Levon M. Khachigian
The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of CancerDrug Targets
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 20 Year: 2022 Page: 3501-3529
Author(s):
Histone Deacetylase Inhibitors in Cancer Therapy
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Alfredo Budillon, Francesca Bruzzese, Elena Di Gennaro
Doi: 10.2174/978160805161811001010079
Phytochemical-based Nanoformulations for Drug-resistant Brain Cancer
Journal: Nanoscience & Nanotechnology-Asia
Volume: 13 Issue: 5 Year: 2023 Page: 1-13
Author(s):
Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 12 Year: 2013 Page: 1072-1082
Author(s): Ruchita S. Selot,Sangeetha Hareendran,Giridhara R. Jayandharan